Mamlins, E. http://orcid.org/0000-0002-3581-2282
Schmitt, D.
Beu, M.
Mattes-György, K.
Henke, J. M.
Antke, C.
Novruzov, E.
Cardinale, J.
Kirchner, J.
Niegisch, G.
Radtke, J. P.
Schimmöller, L.
Albers, P.
Antoch, G.
Giesel, F. L.
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 30 July 2022
Revised: 19 October 2022
Accepted: 24 October 2022
First Online: 11 November 2022
Declarations
:
: All procedures were carried out in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study received approval from the Ethical Committee of Medical Faculty of Heinrich-Heine-University Duesseldorf, Germany (Study-Nr.: 2022-2070).
: FLG has patent applications for PSMA-1007. FLG is also advisor at ABX Advanced Biochemical Compound, Telix Pharmaceuticals, and SOFIE Biosciences. This scientific investigation was also supported by ABX Advanced Biochemical Compound.The other authors declare no conflict of interest regarding this manuscript.